On 23 April, the exhibition of IRB Barcelona's first Artist in Residence will be launched at the Sant Pau Art Nouveau Site, and will be open until 30 June.
Rierola recreates Bosch's work of the same name with images provided by researchers.
This second art and science exhibition at this venue has been organised jointly by IRB Barcelona, the Quo Artis Foundation and the Sant Pau Art Nouveau Site.
Iranian researcher Bahareh Eftekharzadeh did her PhD at IRB Barcelona (Laboratory of Molecular Biophysics, Xavier Salvatella), and she did her postdoc work at the University of Harvard and Massachusetts General Hospital. After that, she has been working in several companies until she took up her current position as Senior Principal Scientist at Nereid Therapeutics, applies leading expertise in soft matter physics and cell biology to pioneer completely new ways to fight intractable diseases, where she is responsible for target discovery, selection, prioritization and...
Have you ever felt like you are not offering the best version of yourself? Although her years in basic research were an enriching experience to her, then there came a time when her professional motivations changed. She then started a period of self-knowledge that led her to work in the pharmaceutical industry.
In her words, she is committed to improving the health of patients and their quality of life. And therefore, she aims to be an active part of technological development, generating new paths for the diagnosis, follow-up and treatment of patients.
We are talking about Marta Clemente, postdoc of the...
Begoña Cánovas is a biochemist and she holds a Master’s in Bioengineering. After a short stay in the Massachusetts General Hospital (Boston), she joined IRB Barcelona’s Signalling and Cell Cycle Laboratory (led by Ángel Nebreda) to do her PhD, which she completed in 2017. She continues to work in this lab as a postdoctoral fellow.
Regarding her research, she participates in various projects, all of which aim to unravel the role of the p38 MAPK protein in different fields, with a special focus on cancer biology.
Using cellular models, her work combines cellular and molecular biology...
The ICREA Acadèmia Award allows university professors to prioritise their dedication to research for 5 years.
The Cell Signaling laboratory, headed by Dr. Eulàlia de Nadal and Dr. Francesc Posas, studies cell adaptation response to stress.
Manuel Serrano, Head of the Cell Plasticity and Senescence lab at IRB Barcelona, has been recognised for his important contributions to the field of cell biology.
Each endowed with €150,000, the Leopold Griffuel Awards are given yearly to two researchers whose exceptional work has accelerated the fight against cancer.
The study of cell lineages seeks to clarify how different types of cells are generated and the important implications of this process for the development of an organism, as well as for cancer.
Alejo Rodríguez-Fraticelli joins IRB Barcelona to head the “Quantitative Stem Cell Dynamics” laboratory.
With this new faculty member, the Institute will have 28 laboratories and 8 scientific platforms.
IRB Barcelona is offering up to 20 places to carry out 4-year doctoral studies in its 28 laboratories.
Highly motivated graduates in scientific disciplines with laboratory experience and good academic records are sought.
In addition to scientific training, those selected will be trained in Open Science, entrepreneurship and interpersonal skills, within the framework of the European project ENABLECARES.
Scientist Cristina Mayor-Ruiz joins IRB Barcelona to lead the “Targeted Protein Degradation and Drug Discovery” laboratory.
With this new group, IRB Barcelona now has 27 laboratories and 8 scientific platforms.
Along with the addition of the new laboratory, the Institute is also launching a Drug Screening Unit devoted to drug discovery.
In this interview, Meritxell Teixidó tells us about her transition from IRB Barcelona research associate to CEO and CSO of the spin-off Gate2Brain, promoted by IRB Barcelona.
Gate2Brain is set up to exploit the technology developed over the last 15 years in the Peptides and Proteins laboratory at IRB Barcelona, of which Meritxell Teixidó has been a research associate.